Risk Factors for Thyroid Cancer in Systemic Lupus Erythematosus

• Main Authors: Yutaka Kawano MD, PhD (Author), Meika Nambu MD (Author), Youji Uejima MD (Author), Satoshi Sato MD, PhD (Author), Eisuke Suganuma MD, PhD (Author), Tadamasa Takano MD, PhD (Author), Tsutomu Oh-ishi MD, PhD (Author)
• Format: Book
• Published: SAGE Publishing, 2017-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

We studied 3 patients with systemic lupus erythematosus (SLE) who developed thyroid cancer (TC). Potential risk factors for TC development was explored. Fifty-three patients with a clinical diagnosis of rheumatic diseases including SLE at our hospital between July 2014 and December 2014 were enrolled. Demographic, clinical, and laboratory findings were retrospectively compared between TC-positive and TC-negative patients. Among rheumatic diseases, lymphadenopathy/splenomegaly at treatment commencement, and lymphadenopathy/splenomegaly, painless ulcer (oral, nasal, or mucosal), and weight loss during the entire study period were precipitating factors. Lower current values of hemoglobin and methylprednisolone pulse therapy favored TC development. In 29 SLE patients, lymphadenopathy/splenomegaly at treatment commencement, lymphadenopathy/splenomegaly and weight loss during the entire study period, urinary granular casts at treatment commencement, and a lower current value of hemoglobin predisposed patients to TC. Several risk factors of TC are present in pediatric SLE. Patients with SLE should be investigated vigorously for TC with ultrasound.

Item Description

2333-794X
10.1177/2333794X17736700